By Ben Butkus

MONTREAL – Early-stage molecular diagnostics firm QuantumDx said today that it has exclusively licensed from Nanosys the rights to use nanowire field effect transistor biosensors in biomarker detection and sequencing applications.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.